Related Experiment Videos
A simple method to determine trypsin and chymotrypsin inhibitory activity
1Biotech Center, Cook College, Rutgers University, Foran Hall, 59 Dudley Road, New Brunswick, NJ 08901-8520, USA. yakoby@aesop.rutgers.edu
Journal of Biochemical and Biophysical Methods
|May 29, 2004
Summary
A modified colorimetric assay accurately quantifies serine protease inhibitors like Bowman-Birk Inhibitor (BBI). This method improves speed and sensitivity for evaluating recombinant BBI (rBBI) expression in yeast.
Area of Science:
- Biochemistry
- Enzymology
- Protein Expression Analysis
Background:
- Serine proteases are crucial enzymes with diverse biological roles.
- Accurate quantification of protease inhibitors is essential for research and development.
- Existing methods like gel activity assays can lack quantification accuracy or sensitivity.
Purpose of the Study:
- To modify and validate a colorimetric assay for serine protease inhibition.
- To quantify recombinant Bowman-Birk Inhibitor (rBBI) expression in Pichia pastoris.
- To compare the modified assay's performance against existing methods.
Main Methods:
- A colorimetric method using N-Acetyl-DL-Phenylalanine beta-Naphthylester (APNE) and o-Dianisidine tetrazotized (oD) was optimized.
- Standard curves for trypsin, chymotrypsin, and Bowman-Birk Inhibitor (BBI) were generated.
- Recombinant BBI (rBBI) expression levels in Pichia pastoris were quantified using the modified assay.
Main Results:
- The modified assay demonstrated strong linearity and sensitivity for trypsin and chymotrypsin.
- IC50 values for trypsin and chymotrypsin inhibition by BBI were determined.
- Quantification of rBBI expression yielded levels of 50-56 ng/microl, consistent with Western blot analysis.
Conclusions:
- The modified colorimetric assay provides a sensitive and reproducible method for quantifying serine protease inhibitors.
- This assay effectively quantifies rBBI expression, overcoming limitations of the gel activity method.
- The developed method combines the sensitivity of gel assays with the quantification capabilities of Western blots.